Chiron Corp HCV E1/E2 Vaccine

计划入组 60 人 · 首次发布于 2007 年 7 月 13 日

Single Ascending Dose Study of Two Liquidia Bupivacaine Formulations

计划入组 29 人 · 首次发布于 2016 年 12 月 6 日

Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp

计划入组 9 人 · 首次发布于 2013 年 6 月 11 日

Filgrastim biosimilar (CJ Corp)

TIL Therapy(NeogenTC Corp)

Project B5(Jw Pharmaceutical Corp)

Liquidia Technologies, Inc.

United States

Nelum Corp.

United States

Androscience Corp

United States

Delaware Judge Limits Liquidia's Patent Defense Strategies in UTC Lung Disease Drug Dispute

Court Dismisses United Therapeutics' Challenge Against Liquidia's YUTREPIA, Clearing Path for May Launch

Supreme Court Declines to Review United Therapeutics' Patent, Clearing Path for YUTREPIA